Wave Life Sciences Ltd (NASDAQ:WVE)’s traded shares stood at 0.65 million during the last session, with the company’s beta value hitting -0.97. At the close of trading, the stock’s price was $6.95, to imply an increase of 2.96% or $0.2 in intraday trading. The WVE share’s 52-week high remains $16.74, putting it -140.86% down since that peak but still an impressive 27.48% since price per share fell to its 52-week low of $5.04. The company has a valuation of $1.08B, with an average of 1.22 million shares in intraday trading volume over the past 10 days and average of 1.39 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Wave Life Sciences Ltd (WVE), translating to a mean rating of 1.23. Of 3 analyst(s) looking at the stock, 0 analyst(s) give WVE a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy.
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
After registering a 2.96% upside in the last session, Wave Life Sciences Ltd (WVE) has traded red over the past five days. The 5-day price performance for the stock is -1.14%, and 6.92% over 30 days. With these gigs, the year-to-date price performance is 32.76%. Short interest in Wave Life Sciences Ltd (NASDAQ:WVE) saw shorts transact 14.88 million shares and set a 14.07 days time to cover.
The extremes give us $15 and $36 for target low and target high price respectively. As such, WVE has been trading -417.99% off suggested target high and -115.83% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 34.27% for the past 5-year period. While 2025 is set for a -52.22% return in earnings, projections for the next 5 years are at -0.22% annually.
WVE Dividends
Wave Life Sciences Ltd has its next earnings report out on 2025-May-08. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
Wave Life Sciences Ltd insiders hold 16.25% of total outstanding shares, with institutional holders owning 84.41% of the shares at 100.79% float percentage. In total, 84.41% institutions holds shares in the company, led by RA CAPITAL MANAGEMENT, L.P.. As of 2024-06-30, the company held over 18.2 million shares (or 14.0527% of shares), all amounting to roughly $90.83 million.
The next major institution holding the largest number of shares is MAVERICK CAPITAL LTD with 7.67 million shares, or about 5.9211% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $38.27 million.
We also have PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund and iShares Trust-iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Wave Life Sciences Ltd (WVE) shares. Going by data provided on Apr 30, 2025 , PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund holds roughly 2.43 shares. This is just over 1.56% of the total shares, with a market valuation of $16.9 million. Data from the same date shows that the other fund manager holds a little less at 2.43, or 1.56% of the shares, all valued at about 16.9 million.
